Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overall and complication‐free survival in a large cohort of patients with β ‐thalassemia major followed over 50 years
Gian Luca Forni, Barbara Gianesin, Khaled M. Musallam, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 3, pp. 381-387
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Αlpha-thalassemia: A practical overview
Khaled M. Musallam, Maria Domenica Cappellini, Thomas D. Coates, et al.
Blood Reviews (2024) Vol. 64, pp. 101165-101165
Open Access | Times Cited: 21
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease
Marta Ferraresi, Daniele Lello Panzieri, Simona Leoni, et al.
European Journal of Pediatrics (2023) Vol. 182, Iss. 6, pp. 2509-2519
Open Access | Times Cited: 17
Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study
Khaled M. Musallam, Susanna Barella, Raffaella Origa, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2283-2297
Closed Access | Times Cited: 5
Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East
Amal El‐Beshlawy, Hany Dewedar, Salwa Hindawi, et al.
Blood Reviews (2023), pp. 101138-101138
Open Access | Times Cited: 12
Defining curative endpoints for transfusion‐dependent β‐thalassemia in the era of gene therapy and gene editing
Selim Corbacioglu, Haydar Frangoul, Franco Locatelli, et al.
American Journal of Hematology (2023) Vol. 99, Iss. 3, pp. 422-429
Open Access | Times Cited: 11
Quality of life, mood disorders, and cognitive impairment in adults with β-thalassemia
Maya Bizri, Rawan Koleilat, Nathalie Akiki, et al.
Blood Reviews (2024) Vol. 65, pp. 101181-101181
Closed Access | Times Cited: 4
Global burden and unmet needs in the treatment of transfusion-dependent β-thalassemia
Gian Luca Forni, Giuliano Grazzini, Jeanne Boudreaux, et al.
Frontiers in Hematology (2023) Vol. 2
Open Access | Times Cited: 10
Introduction to a How I Treat series on iron overload in hematologic disorders
Thomas D. Coates
Blood (2025) Vol. 145, Iss. 4, pp. 349-350
Closed Access
Thalassemias and Sickle Cell Diseases in Pregnancy: SITE Good Practice
Valeria Maria Pinto, Rosanna Cima, Rosario Di Maggio, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 948-948
Open Access
What we now BELIEVE is achievable with luspatercept in transfusion-dependent β-thalassaemia
Khaled M. Musallam
The Lancet Haematology (2025)
Closed Access
TIF Guidelines for the Management of Transfusion‐Dependent β‐Thalassemia
Khaled M. Musallam, Maria Domenica Cappellini, John B. Porter, et al.
HemaSphere (2025) Vol. 9, Iss. 3
Open Access
Cardiac Conduction Disorders Due to Acquired or Genetic Causes in Young Adults: A Review of the Current Literature
Cristina Balla, Luca Canovi, Marco Zuin, et al.
Journal of the American Heart Association (2025)
Open Access
A Chinese pediatric patient with thalassemia traits and compound heterozygous mutations in the PIEZO1 g ene suspected of having dehydrated hereditary stomatocytosis
W. Chen, Xinyu Li, Hua‐Qing Yang, et al.
Hematology (2025) Vol. 30, Iss. 1
Open Access
Sickle cell disease and acute leukemia: one case report and an extensive review
Giovanna Cannas, Solène Poutrel, Maël Heiblig, et al.
Annals of Hematology (2023) Vol. 102, Iss. 7, pp. 1657-1667
Open Access | Times Cited: 8
Iron chelation therapy for children with transfusion‐dependent β‐thalassemia: How young is too young?
Gian Luca Forni, Antonis Kattamis, Kevin H.M. Kuo, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 8
Closed Access | Times Cited: 2
Differential effects of iron chelators on iron burden and long-term morbidity and mortality outcomes in a large cohort of transfusion-dependent β-thalassemia patients who remained on the same monotherapy over 10 years
Khaled M. Musallam, Susanna Barella, Raffaella Origa, et al.
Blood Cells Molecules and Diseases (2024) Vol. 107, pp. 102859-102859
Open Access | Times Cited: 2
Anemia and iron overload as prognostic markers of outcomes in β-thalassemia
Khaled M. Musallam, Sujit Sheth, Maria Domenica Cappellini, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 9, pp. 631-642
Closed Access | Times Cited: 2
Causes of Death and Mortality Trends in Individuals with Thalassemia in the United States, 1999-2020
Jia Yi Tan, Yong Hao Yeo, Kok Hoe Chan, et al.
Journal of Blood Medicine (2024) Vol. Volume 15, pp. 331-339
Open Access | Times Cited: 2
Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: impact of the oral chelators’ era
Morgan Pines, Dorothy A. Kleinert, Charlene Thomas, et al.
Annals of Hematology (2024) Vol. 103, Iss. 12, pp. 5229-5234
Closed Access | Times Cited: 2
Cardiac complications in thalassemia throughout the lifespan: Victories and challenges
John C. Wood
Annals of the New York Academy of Sciences (2023) Vol. 1530, Iss. 1, pp. 64-73
Closed Access | Times Cited: 6
Inflammatory and senescence‐associated mediators affect the persistence of humoral response to COVID‐19 mRNA vaccination in transfusion‐dependent beta‐thalassemic patients
Veronica Bordoni, Maddalena Casale, Valeria Maria Pinto, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 6
Open Access | Times Cited: 4
Luspatercept for transfusion-dependent β-thalassemia: time to get real
Khaled M. Musallam, Sujit Sheth, Maria Domenica Cappellini, et al.
Therapeutic Advances in Hematology (2023) Vol. 14
Open Access | Times Cited: 4
Unplanned pregnancy in women with beta‐thalassaemia treated with luspatercept
Eleonora Zaccheddu, Antonietta Zappu, Susanna Barella, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 6, pp. 2505-2507
Open Access | Times Cited: 1
Association between Epicardial Adipose Tissue and Atrial Fibrillation in Patients with Transfusion-Dependent β-Thalassemia
Michele Malagù, Elisabetta Tonet, Giovanni Orazio, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3471-3471
Open Access | Times Cited: 1
Establishment of the Abu Dhabi Emirate Thalassemia Longitudinal Cohort (AD-TLC): leveraging the power of observation
Khaled M. Musallam, Wesam Ahmed, Mozah Almarshoodi, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2277-2278
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top